The Role of Serum CEA and CA19-9 in Efficacy Evaluations and Progression-Free Survival Predictions for Patients Treated with Cetuximab Combined with FOLFOX4 or FOLFIRI as a First-Line Treatment for Advanced Colorectal Cancer

BACKGROUND: Previously, it was demonstrated that serum levels of tumor markers, CEA and CA19-9, correlated with chemotherapy. Consequently, it has been hypothesized that dynamic monitoring of changes in these markers may predict the shrinkage or growth of colorectal cancers. To test this hypothesis,...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Dis Markers
Hlavní autoři: Jia, Jun, Zhang, Pengfei, Gou, Miaomiao, Yang, Fan, Qian, Niansong, Dai, Guanghai
Médium: Artigo
Jazyk:Inglês
Vydáno: Hindawi 2019
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6360556/
https://ncbi.nlm.nih.gov/pubmed/30805037
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/6812045
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky